4.3 Review

Nanotechnology: Its Application in Treating Neurodegenerative Diseases

Journal

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS
Volume 20, Issue 1, Pages 34-53

Publisher

BENTHAM SCIENCE PUBL
DOI: 10.2174/1871527319666200916121515

Keywords

Nanotechnology; nanoparticles; neurodegenerative disease; Alzheimer's disease; Parkinson's disease; Huntington's disease

Ask authors/readers for more resources

Neurodegenerative diseases like Alzheimer's, Parkinson's, and Huntington's disease have a significant impact on quality of life, but current treatment strategies often face limitations in crossing the Blood-Brain Barrier. Nanotechnology shows promise in addressing these challenges over the past 20 years.
Neurodegenerative diseases such as Alzheimer's, Parkinson's and Huntington disease have serious concern due to its effect on the quality of life of affected persons. They have some limitations at diagnostic as well as the treatment level. Introducing nanotechnology, for the treatment of these diseases may contribute significantly to solve the problem. There are several treatment strategies for the neurodegenerative diseases, but most of them fail to cross the Blood-Brain Barrier (BBB). The present review highlights the application of nanotechnology during last the 20 years for the treatment of neurodegenerative diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available